Anti-covid vaccine for the age group 5-11, the first data will arrive in the autumn “in order to understand if the positive benefit-risk ratio remains valid”. This was explained by Marco Cavaleri, head of Vaccines and Therapeutic Products for Covid-19 of the European Medicines Agency Ema, answering a question at a press conference. Read also As for adolescents who can already be immunized, the expert confirmed as “positive the benefit-risk ratio of the two anti-Covid mRna vaccines”, namely Pfizer / BioNTech and Moderna, “which are authorized for use by 12 years and up “.
Welcome! Log into your account
Recover your password
A password will be e-mailed to you.